Spero Therapeutics (SPRO) Insider Trading & Ownership → Major Elon Musk Crypto Leak Revealed (From Crypto 101 Media) (Ad) Free SPRO Stock Alerts $1.75 +0.02 (+1.16%) (As of 03/27/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Spero Therapeutics (NASDAQ:SPRO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.21%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$69,298.26 Get SPRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Spero Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SPRO Insider Buying and Selling by Quarter Ad DTICBOE shift unlocks new weekend income strategyYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. You're probably wondering, “Okay… But how does that affect me?” This perk now allows everyday traders like yourself to target extra income over the weekend. Check out this training for the full story! Spero Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/13/2023Kamal HamedInsiderSell39,496$1.27$50,159.92 8/29/2023Sath ShuklaCEOSell4,163$1.30$5,411.90 8/28/2023Ankit MahadeviaDirectorSell9,040$1.26$11,390.40 8/28/2023Timothy KeutzerInsiderSell1,854$1.26$2,336.04 (Data available from 1/1/2013 forward) SPRO Insider Trading Activity - Frequently Asked Questions Who is on Spero Therapeutics's Insider Roster? The list of insiders at Spero Therapeutics includes Ankit Mahadevia, Aquilo Capital Management, Llc, Kamal Hamed, Sath Shukla, and Timothy Keutzer. Learn more on insiders at SPRO. What percentage of Spero Therapeutics stock is owned by insiders? 4.21% of Spero Therapeutics stock is owned by insiders. Learn more on SPRO's insider holdings. Which Spero Therapeutics insiders have been buying company stock? The following insider purchased SPRO shares in the last 24 months: Aquilo Capital Management, Llc ($647,669.48). How much insider buying is happening at Spero Therapeutics? Insiders have purchased a total of 89,727 SPRO shares in the last 24 months for a total of $647,669.48 bought. Which Spero Therapeutics insiders have been selling company stock? The following insiders have sold SPRO shares in the last 24 months: Ankit Mahadevia ($33,628.06), Aquilo Capital Management, Llc ($4,279,041.00), Kamal Hamed ($50,159.92), Sath Shukla ($28,159.35), and Timothy Keutzer ($8,648.88). How much insider selling is happening at Spero Therapeutics? Insiders have sold a total of 1,987,550 Spero Therapeutics shares in the last 24 months for a total of $4,399,637.21 sold. More Insider Trading Tools from MarketBeat Related Companies: Assertio Insider Trades Sagimet Biosciences Insider Trades Corvus Pharmaceuticals Insider Trades Annovis Bio Insider Trades Equillium Insider Trades ProPhase Labs Insider Trades Vaccitech Insider Trades Vaxxinity Insider Trades Eton Pharmaceuticals Insider Trades Celularity Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders Are Buying That Analysts LoveInsider Selling of Amazon Spikes in Q1, but it's Not Time to Sell3 Small Dividend Paying Banks Insiders are Buying3 Stocks Insiders are Buying at New HighsInsider selling at JPM: A Closer Look Amidst Historic CEO Sale This page (NASDAQ:SPRO) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.